Skip to main content
. 2015 May 21;5:10516. doi: 10.1038/srep10516

Table 1. Basic characteristics of the studies included in this meta-analysis.

Study Quality (scores) Regimen n Age Male(%) Stage(%) CR + PR
Furuse et al.14/1992 3 NDP 90 mg/m2d1 + VDS 3mg/m2d1,8 68 62 68 65 8
    DDP 90 mg/m2d1 + VDS 3 mg/m2d1,8 62 62 65 45 9
Xu et al.15/2002 3 NDP 80–100mg/m2d1 + VDS 3 mg/m2d1,5,q3w 60 56 70 – 16
    DDP 30mg/m2d1–3 + VDS 3 mg/m2d1,5,q3w 62 53 84 – 16
Li et al.16/2006 3 NDP 80mg/m2d1 + NVB 25 mg/m2d1,8,q4w 25 51 72 – 8
    DDP 80 mg/m2d1 + NVB 25 mg/m2d1,8,q4w 21       5
Liao et al.17/2007 3 NDP 100 mg/m2d1 + GEM 1000 mg/m2d1,8,q3w 24 56 67 63 9
    DDP 80–100 mg/m2d1 + GEM 1000 mg/m2d2,8,q3w 19       7
Chen et al.18/2007 3 NDP 30 mg/m2d1–3 + PTX 175 mg/m2d1,q4w 32 52 66 59 13
    DDP 30 mg/m2d1–3 + PTX 175 mg/m2d1,q4w 28 56 71 57 13
Li et al.19/2009 2 NDP 80 mg/m2d1 + PTX 175 mg/m2d1,q3w 30 47 50 – 11
    DDP 80 mg/m2d1 + PTX 175 mg/m2d1,q3w 30 47 47 – 10
Lu et al.20/2009 3 NDP 80 mg/m2d1 + NVB 25 mg/m2d1,8,q4w 30 54 77 – 10
    DDP 30 mg/m2d1–3 + NVB 25 mg/m2d1,8,q4w 30       9
Sun et al.21/2010 2 NDP 100 mg/m2d1 + PTX 135 mg/m2d1,8,q3w 76 56 66 43 38
    DDP 50 mg/m2d2,3 + PTX 135 mg/m2d1,8,q3w 74 57 62 46 36
Wang et al.22/2011 2 NDP 30 mg/m2d1–3 + PTX Lip 135 mg/m2d1,q4w 37 57 57 – 15
    DDP 30 mg/m2d1–3 + PTX Lip 135 mg/m2d1,q4w 37       16
Xia et al.23/2011 3 NDP 80 mg/m2d1 + GEM 1000 mg/m2d1,8,q4w 126 67 83 24 48
    DDP 75 mg/m2d1 + GEM 1000 mg/m2d1,8,q4w 120 66 82 26 44
Li et al.24/2012 3 NDP 80 mg/m2d1 + GEM 1250 mg/m2d1,8,q3w 29 54 69 59 13
    DDP 75 mg/m2d1 + GEM 1250 mg/m2d1,8,q3w 27 51 85 63 11
Liang et al.25/2012 3 NDP 80 mg/m2d1 + GEM 1000 mg/m2d1,8,q3w 31 69 68 33 12
    DDP 25 mg/m2d1–3 + GEM 1000 mg/m2d1,8,q3w 29       13
Wang et al.26/2012 3 NDP 40–50 mg/m2d1,8 + TXT 30–35 mg/m2d1,8,q3w 41 56 61 54 16
    DDP 25–30 mg/m2d1–3 + TXT 75 mg/m2d1,q3w 44 54 55 45 17
Qiao et al.27/2013 2 NDP 75 mg/m2d1 + TXT 75 mg/m2d1,q3w 25 50 80 28 10
    DDP 75 mg/m2d1 + TXT 75 mg/m2d1,q3w 25 51 72 44 10

NDP, nedaplatin; DDP, cisplatin; VDS, vindesine; NVB, vinorelbine; GEM, gemcitabine; PTX, paclitaxel; PTX Lip, paclitaxel liposome; TXT, docetaxel; CR, complete response; PR, partial response.